R. J. Lamping

568 total citations
17 papers, 479 citations indexed

About

R. J. Lamping is a scholar working on Hematology, Molecular Biology and Surgery. According to data from OpenAlex, R. J. Lamping has authored 17 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 4 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in R. J. Lamping's work include Blood Coagulation and Thrombosis Mechanisms (6 papers), Blood properties and coagulation (2 papers) and Genetic factors in colorectal cancer (2 papers). R. J. Lamping is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (6 papers), Blood properties and coagulation (2 papers) and Genetic factors in colorectal cancer (2 papers). R. J. Lamping collaborates with scholars based in Netherlands, Italy and Canada. R. J. Lamping's co-authors include J W ten Cate, Auguste Sturk, Augueste Sturk, Fenny Berends, J.J.J. Borm, J A Hoek, Giuseppe Avvisati, Maria Concetta Petti, Jan W. ten Cate and Franco Mandelli and has published in prestigious journals such as Gastroenterology, Scientific Reports and Clinical Chemistry.

In The Last Decade

R. J. Lamping

17 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. J. Lamping Netherlands	10	225	110	84	83	76	17	479
Jerrold A. Clark United States	5	217 1.0×	38 0.3×	72 0.9×	64 0.8×	86 1.1×	7	477
H. Rasche Germany	10	161 0.7×	42 0.4×	58 0.7×	78 0.9×	101 1.3×	44	446
M.J. Allington United Kingdom	13	189 0.8×	80 0.7×	60 0.7×	60 0.7×	163 2.1×	26	530
Lisa M. Regan United States	12	729 3.2×	83 0.8×	113 1.3×	62 0.7×	73 1.0×	16	887
A. Wehmeier Germany	11	259 1.2×	112 1.0×	37 0.4×	47 0.6×	61 0.8×	31	591
Nathalie Hézard France	15	315 1.4×	50 0.5×	155 1.8×	126 1.5×	51 0.7×	37	545
D.C. RIJKEN Netherlands	6	223 1.0×	84 0.8×	41 0.5×	49 0.6×	84 1.1×	8	455
Mary Jane Patch United States	14	644 2.9×	84 0.8×	75 0.9×	76 0.9×	176 2.3×	19	950
TC Wun United States	6	566 2.5×	66 0.6×	172 2.0×	72 0.9×	112 1.5×	9	785
PM Jansen Netherlands	9	231 1.0×	68 0.6×	76 0.9×	57 0.7×	62 0.8×	11	660

Countries citing papers authored by R. J. Lamping

Since Specialization

Citations

This map shows the geographic impact of R. J. Lamping's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. J. Lamping with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. J. Lamping more than expected).

Fields of papers citing papers by R. J. Lamping

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. J. Lamping. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. J. Lamping. The network helps show where R. J. Lamping may publish in the future.

Co-authorship network of co-authors of R. J. Lamping

This figure shows the co-authorship network connecting the top 25 collaborators of R. J. Lamping. A scholar is included among the top collaborators of R. J. Lamping based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. J. Lamping. R. J. Lamping is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Liu, Jingjing, Wendy J. C. Prager‐van der Smissen, Marjanka K. Schmidt, et al.. (2016). Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk. Scientific Reports. 6(1). 30026–30026. 1 indexed citations

Ouweland, Ans M.W. van den, et al.. (2010). Identification of a large rearrangement in CYLD as a cause of familial cylindromatosis. Familial Cancer. 10(1). 127–132. 22 indexed citations

Lamping, R. J., PM Jansen, Maria Prins, et al.. (1997). Antithrombin Acts as a Negative Acute Phase Protein as Established with Studies on HepG2 Cells and in Baboons. Thrombosis and Haemostasis. 78(3). 1088–1092. 62 indexed citations

Lamping, R. J., et al.. (1996). Fetal and Neonatal Development of Antithrombin III Plasma Activity and Liver Messenger RNA Levels in Sheep. Pediatric Research. 39(4). 685–691. 8 indexed citations

Monajemi, Houshang, et al.. (1996). Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing protein. Gastroenterology. 110(3). 733–739. 72 indexed citations

Sturk, Augueste, et al.. (1995). The Influence of Insulin, ß-Estradiol, Dexamethasone and Thyroid Hormone on the Secretion of Coagulant and Anticoagulant Proteins by HepG2 Cells. Thrombosis and Haemostasis. 74(2). 686–692. 19 indexed citations

Defesche, Joep C., D.E. van Diermen, Peter Lansberg, et al.. (1993). South African founder mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia in the Dutch population. Human Genetics. 92(6). 567–570. 24 indexed citations

Defesche, Joep C., et al.. (1993). Analysis of the Afrikaner mutation in exon 9 of the low-density lipoprotein receptor gene in a large Dutch kindred suffering from familial hypercholesterolaemia.. PubMed. 42(1-2). 53–60. 3 indexed citations

Hoek, J A, Auguste Sturk, J W ten Cate, et al.. (1988). Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes in plasma.. Clinical Chemistry. 34(10). 2058–2062. 102 indexed citations

10.

Avvisati, Giuseppe, Jan W. ten Cate, Augueste Sturk, et al.. (1988). Acquired alpha‐2‐antiplasmin deficiency in acute promyelocytic leukaemia. British Journal of Haematology. 70(1). 43–48. 85 indexed citations

11.

Hoek, J A, et al.. (1987). THROMBIN-ANTITHROMBIN III (TAT) COMPLEXES: A STUDY IN CONSECUTIVE PATIENTS SUSPECTED OF DIC. Thrombosis and Haemostasis. 1 indexed citations

12.

Knot, E.A.R., et al.. (1986). α2-Antiplasmin: Functional Characterization and Metabolism in a Heterozygote Deficient Patient. Thrombosis and Haemostasis. 55(3). 375–378. 12 indexed citations

13.

Kahlé, L H, et al.. (1984). Antithrombin III in Oral Contraceptive Users and During Normotensive Pregnancy. Acta Obstetricia Et Gynecologica Scandinavica. 63(1). 57–61. 17 indexed citations

14.

Cate, Hugo Ten, et al.. (1984). Automated amidolytic method for determining heparin, a heparinoid, and a low-Mr heparin fragment, based on their anti-Xa activity.. Clinical Chemistry. 30(6). 860–864. 36 indexed citations

15.

Cate, J W ten, et al.. (1983). “Morning‐After Pill” and Antithrombin III. Acta Obstetricia Et Gynecologica Scandinavica. 62(4). 359–363. 6 indexed citations

16.

Kahlé, L H, et al.. (1979). Evaluation Of An Automated Amidolytic Antiplasmin Assay. Thrombosis and Haemostasis. 6 indexed citations

17.

Schipper, H G, R. J. Lamping, L H Kahlé, & J W ten Cate. (1979). Antithrombin-III Transfusion in Patients with Liver Cirrhosis. Thrombosis and Haemostasis. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact